Search Results

The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye.

• Authors : Demir M; Division of Allergy and Immunology, Department of Internal Medicine, Ege University Faculty of Medicine, Izmir 35100, Türkiye.; Tunakan Dalgic C

Subjects: Asthma*/Asthma*/Asthma*/complications ; Asthma*/Asthma*/Asthma*/drug therapy ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/complications

• Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Mar 08; Vol. 60 (3). Date of Electronic Publication: 2024 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet

Record details

Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study.

• Authors : Pini, Laura^1,2 (AUTHOR) ; Bagnasco, Diego³ (AUTHOR); Beghè, Bianca⁴ (AUTHOR)

• Source: Journal of Clinical Medicine. May2024, Vol. 13 Issue 10, p3013. 18p.

Record details

Eosinophilic Patterns in Patients with Seasonal Allergy Affected by Bronchial Asthma and Rhinitis/Rhinosinusitis: Efficacy of Benralizumab in Patients with the Persistent Pattern.

• Authors : D'Aiuto, Valentina¹ (AUTHOR) ; Mormile, Ilaria¹ (AUTHOR) ; Granata, Francescopaolo¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Feb2024, Vol. 13 Issue 3, p754. 17p.

Record details

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience.

• Authors : Scioscia, Giulia¹ (AUTHOR) ; Tondo, Pasquale¹ (AUTHOR) ; Nolasco, Santi² (AUTHOR)

• Source: Journal of Clinical Medicine. Jul2023, Vol. 12 Issue 13, p4362. 14p.

Record details

Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis.

• Authors : Pelaia, Corrado¹ (AUTHOR) ; Pelaia, Giulia¹ (AUTHOR) ; Maglio, Angelantonio² (AUTHOR)

• Source: Journal of Clinical Medicine. May2023, Vol. 12 Issue 10, p3371. 16p.

Record details

Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab.

• Authors : Ledda, Andrea Giovanni¹ (AUTHOR) ; Costanzo, Giulia¹ (AUTHOR) ; Sambugaro, Giada¹ (AUTHOR)

• Source: Life (2075-1729). Sep2023, Vol. 13 Issue 9, p1884. 11p.

Record details

Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future.

• Authors : Ramírez-Jiménez, Fernando¹ (AUTHOR); Pavón-Romero, Gandhi Fernando¹ (AUTHOR); Velásquez-Rodríguez, Juancarlos Manuel¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Feb2023, Vol. 16 Issue 2, p270. 20p.

Record details

Switching Biological Therapies in Severe Asthma.

• Authors : Scioscia, Giulia¹ (AUTHOR) ; Nolasco, Santi^2,3 (AUTHOR) ; Campisi, Raffaele² (AUTHOR)

Subjects: *MONOCLONAL antibodies; *BIOTHERAPY; *DUPILUMABITALY

• Source: International Journal of Molecular Sciences. Jun2023, Vol. 24 Issue 11, p9563. 18p.

Record details

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy.

• Authors : Bagnasco, Diego^1,2 (AUTHOR) ; Savarino, Edoardo Vincenzo³ (AUTHOR); Yacoub, Mona-Rita^4,5 (AUTHOR)

• Source: Pharmaceutics. Sep2023, Vol. 15 Issue 9, p2359. 17p.

Record details

Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study.

• Authors : Higo, Hisao^1,2,3 (AUTHOR) ; Ichikawa, Hirohisa⁴ (AUTHOR); Arakawa, Yukako⁴ (AUTHOR)

• Source: Journal of Clinical Medicine. Aug2023, Vol. 12 Issue 16, p5174. 12p.

Record details